KalVista Pharmaceuticals
KALV
#6308
Rank
ยฃ0.61 B
Marketcap
ยฃ12.23
Share price
0.99%
Change (1 day)
66.87%
Change (1 year)

Revenue for KalVista Pharmaceuticals (KALV)

Revenue in 2025 (TTM): ยฃ11.26 Million

According to KalVista Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ11.32 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for KalVista Pharmaceuticals from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ11.26 M
2024 N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 ยฃ2.8 M-68.8%
2019 ยฃ8.99 M-36.73%
2018 ยฃ14.21 M423.65%
2017 ยฃ2.71 M1144.92%
2016 ยฃ0.21 M1014.03%
2015 ยฃ0.01 M5.06%
2014 ยฃ0.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA